Biogen Inc.
BIIB
$182.31
$1.560.86%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -0.41% | 32.10% | 26.80% | 40.57% | 10.49% |
| Total Depreciation and Amortization | 21.36% | 30.24% | 33.75% | 36.05% | 32.62% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 40.30% | -12.66% | 1.81% | 34.31% | 73.56% |
| Change in Net Operating Assets | -10.70% | -14.65% | 62.50% | 76.08% | 15.84% |
| Cash from Operations | 15.35% | 18.66% | 56.93% | 85.85% | 56.44% |
| Capital Expenditure | 16.93% | 36.93% | 43.46% | 44.51% | 39.77% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 100.00% | 84.48% | 84.48% | 84.48% | 73.72% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -102.14% | -101.77% | -88.93% | -86.16% | -86.47% |
| Cash from Investing | 88.97% | 34.60% | 75.72% | 80.51% | 60.08% |
| Total Debt Issued | -- | 73.83% | -- | -- | -100.00% |
| Total Debt Repaid | -34.62% | -19.87% | 79.34% | 19.74% | -713.01% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -273.60% | 14.29% | 50.58% | 11.84% | 23.94% |
| Cash from Financing | 88.26% | 93.07% | -8.10% | -557.80% | -269.73% |
| Foreign Exchange rate Adjustments | -54.21% | 527.88% | -28.75% | -292.88% | 0.37% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 467.52% | 219.89% | 183.56% | 155.93% | 57.58% |